4.7 Article

The alanine-serine-cysteine-1 (Asc-1) transporter controls glycine levels in the brain and is required for glycinergic inhibitory transmission

Journal

EMBO REPORTS
Volume 16, Issue 5, Pages 590-598

Publisher

WILEY-BLACKWELL
DOI: 10.15252/embr.201439561

Keywords

glycine receptor; GlyT2; hyperekplexia; non-ketotic hyperglycinemia; D-serine

Funding

  1. Israel Science Foundation
  2. Legacy Heritage Fund
  3. Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain

Ask authors/readers for more resources

Asc-1 (SLC7A10) is an amino acid transporter whose deletion causes neurological abnormalities and early postnatal death in mice. Using metabolomics and behavioral and electrophysiological methods, we demonstrate that Asc-1 knockout mice display a marked decrease in glycine levels in the brain and spinal cord along with impairment of glycinergic inhibitory transmission, and a hyperekplexia-like phenotype that is rescued by replenishing brain glycine. Asc-1 works as a glycine and L-serine transporter, and its transport activity is required for the subsequent conversion of L-serine into glycine invivo. Asc-1 is a novel regulator of glycine metabolism and a candidate for hyperekplexia disorders.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available